Recombinant lymphotoxin alpha derivative (Shanghai Fudan-Zhangjiang)
重组人淋巴毒素α衍生物（上海复旦张江生物医药）
Report date: 2023/04/25 13:50:55
Base Information
Drug NameRecombinant lymphotoxin alpha derivative (Shanghai Fudan-Zhangjiang)
Drug Alias Name +[6]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (IND)
Highest Status in ChinaDiscontinued
Originator CompaniesShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesN/A
Inactive CompaniesShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A